press release – Piazza Carlo Giuliani http://piazzacarlogiuliani.org/ Mon, 14 Mar 2022 11:00:00 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://piazzacarlogiuliani.org/wp-content/uploads/2021/03/cropped-icon-1-32x32.png press release – Piazza Carlo Giuliani http://piazzacarlogiuliani.org/ 32 32 Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and its Proprietary Ultra-High Throughput Screening Platform https://piazzacarlogiuliani.org/ginkgo-bioworks-signs-definitive-agreement-to-acquire-fgen-ag-a-leading-bioengineering-company-and-its-proprietary-ultra-high-throughput-screening-platform/ Mon, 14 Mar 2022 11:00:00 +0000 https://piazzacarlogiuliani.org/ginkgo-bioworks-signs-definitive-agreement-to-acquire-fgen-ag-a-leading-bioengineering-company-and-its-proprietary-ultra-high-throughput-screening-platform/

BOSTON and BASEL, Switzerland, March 14, 2022 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), the leading horizontal cell programming platform, today announced that it has entered into a definitive agreement to acquire FGen AG (“FGen”), a Swiss-based company specializing in the development and optimization of strains. FGen has developed an ultra-high throughput (uHT) screening platform based on nanoliter reactor technology. Ginkgo believes that FGen’s technology will significantly enhance Ginkgo’s cell screening capabilities and allow Ginkgo to explore larger expanses of genetic opportunities, increasing the likelihood of finding enzymes, pathways and strains or cell lines. which operate under various product specifications.

Ginkgo and FGen expect to close the transaction soon. Post-closing, Ginkgo expects that the integration of the FGen platform can significantly increase the capability of Ginkgo’s Design-Build-Test-Learn strain development engine, a foundation of Ginkgo’s technology stack. By adding FGen’s uHT screening platform to its existing HT screening systems, Ginkgo seeks to be able to routinely analyze the performance of millions of genetic prototypes in a pooled format, thereby improving the quality of candidate results that feed downstream workflows for strain characterization and validation. FGen’s platform is extremely flexible for all target organizations, pathways and products. The platform can be deployed to screen for both intracellular and secreted target products as well as small molecules and proteins. It can also host various organisms including bacteria, yeasts, filamentous species and mammalian cells.

“Ginkgo is committed to investing in creating the first cellular programming platform by integrating best-in-class tools from around the world and deploying them widely across our programs,” said Township of Barry, co-founder and chief technology officer of Ginkgo. “We have worked with the FGen team for several years and believe that their world-class technology and scientists will further enhance our ability to explore an exponentially wider design space and deliver more value to our customers.”

“Our team has spent the past decade building one of the world’s most advanced screening platforms in hopes of enabling breakthrough discoveries and products across all industries,” said Andreas Meyer, CEO of FGen. “We are thrilled to be welcomed onto the Ginkgo platform where we can deploy this technology much more widely and better support customers and their world-changing work.”

Under the terms of the transaction, FGen will receive an upfront payment and additional contingent consideration related to, among other things, the successful integration and deployment of FGen technology into Ginkgo programs.

About Ginkgo Bioworks
Ginkgo is building a platform to allow customers to program cells as easily as we can program computers. The Company’s platform enables biotechnology applications in various markets, from food and agriculture to industrial chemicals and pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapy discovery. For more information, visit www.ginkgobioworks.com.

About FGen AG
FGen is a Swiss start-up founded in 2011 in Basel, Switzerland as a spin-off from the Department of Biosystems Science and Engineering at ETH Zurich. As a contract research organization, we collaborate with partners in biotechnology, life sciences, food and pharmaceuticals to develop microbes, cells, chemicals and proteins for various apps. For more information, visit www.fgen.ch.

Ginkgo Bioworks Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of federal securities laws, including statements regarding its expectations regarding the prompt closing of the transaction, the potential success of the acquisition and Ginkgo’s cellular programming platform. These forward-looking statements are generally identified by the words “believe”, “project”, “potential”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future “, “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will,” “will,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, therefore, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from forward-looking statements contained herein, including, but not limited to: (i) the effect of the business combination with Soaring Eagle Acquisition Corp. (“Soaring Eagle”) on Ginkgo’s business, relationships, performance and business in general, (ii) risks whether the business combination disrupts Ginkgo’s current plans and potential difficulties in retaining Ginkgo’s employees, (iii) the outcome of any legal proceedings that may be brought against Ginkgo related to its business combination with Soaring Eagle , (iv) volatility in the price of Ginkgo’s securities now that it is a public company due to various factors, including changes in the competitive and highly regulated industries in which Ginkgo plans to operate, variations in performance between competitors, changes in laws and regulations affecting Ginkgo’s business and changes in the combined capital structure, (v) the ability to implement plans, forecasts and other expectations after completion of the business combination, and identifying and realizing additional opportunities, and (vi) the risk of reduced demand for products using synthetic biology. ic. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of Ginkgo’s Quarterly Report on Form 10-Q filed with the United States Securities and Exchange Commission (the “SEC”). ) the November 15, 2021 and other documents filed by Ginkgo from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to place undue reliance on forward-looking statements, and Ginkgo undertakes no obligation and does not intend to update or revise such forward-looking statements, whether as a result of new information, future events or otherwise. Ginkgo gives no assurance that it will meet its expectations.

GINKGO BIOWORKS INVESTOR CONTACT:
[email protected]ginkgobioworks.com

GINKGO BIOWORKS MEDIA CONTACT:
[email protected]

SOURCE Ginkgo Bioworks

]]>
Series TO1 warrants exercised approximately 75.3% and Veg of Lund receives approximately SEK 6.53 million https://piazzacarlogiuliani.org/series-to1-warrants-exercised-approximately-75-3-and-veg-of-lund-receives-approximately-sek-6-53-million/ Sat, 12 Mar 2022 08:11:03 +0000 https://piazzacarlogiuliani.org/series-to1-warrants-exercised-approximately-75-3-and-veg-of-lund-receives-approximately-sek-6-53-million/

Today, Veg from Lund AB (pub) (“Vegetable of lund” or the “Company”) announces the result of the exercise of the series TO1 warrants (the “Warrants”), which were issued during the third quarter of 2021. In total, 590,865 subscription were exercised, corresponding to approximately 75.3% of the total number of Warrants in circulation, for the subscription of 590,865 shares at a subscription price of SEK11.06 per new share. Lund Vegetablesthus receives approximately 6.53 million Swedish crowns before issuing fees by exercising the Warrants.

“It’s gratifying that so many people have chosen to participate in the financing of Lund Vegetables and our continued launch of DUG®. The main shareholders and members of the Board of Directors have exercised their warrants and thus show their continued support in the important phase that the company is going through. We can now focus on increasing market share, mainly in the UK and Sweden while the board continues to actively evaluate various financing options to ensure the company’s long-term funding and optimal capital structure based on the ongoing launch,” said Emma Källqvist, interim CEO. and Chief Financial Officer of Lund Vegetables.

Context:

The exercise period of the Warrants took place from February 25, 2022 up to and including March 10, 2022. The subscription price per share subscribed by exercise of the BSAs was set at SEK11.06 as communicated by press release on February 24, 2022.

A total of 590,865 warrants were exercised to subscribe for 590,865 shares, which means that approximately 75.3% of all outstanding warrants were exercised to subscribe for shares.

The warrants exercised have been replaced by interim shares (IA), pending registration with the Swedish Companies Registration Office. The provisional shares should be converted into shares within approximately three (3) weeks.

Number of shares, share capital and dilution:

Through the exercise of the Warrants, the number of shares in Lund Vegetables increases by 590,865 shares, from 12,224,336 shares to 12,815,201 shares. The share capital increases with SEK37,815.360 from SEK 782,357.504 for SEK 820,172,864.

For existing shareholders who have not exercised any Warrants, the dilution amounts to approximately 4.6% based on the number of shares after the exercise of the Warrants.

Advisors

Mangold Fondkommission AB is the financial advisor and issuing agent and Fredersen Advokatbyrå is the legal advisor to Lund Vegetables within the framework of the exercise of the Warrants.

For more information regarding the Warrants, please contact:

Mangold Fondkommission AB
Telephone: +46 8 5050 1595
E-mail: transmitter@mangold.se

For more information please contact:

Veg from Lund AB
Emma Källqvist (acting CEO and CFO)
Telephone: +46 721 869 018
E-mail: emma.kallqvist@vegoflund.se

This information is such as Lund Vegetables is required to make public in accordance with the EU Market Abuse Regulation. The information has been submitted for publication, through the above contact person, the March 12, 2022 at 09:10 CET.

On Veg from Lund AB (pub)
Lund Vegetables develops unique plant foods that meet consumer demands for taste and sustainability. The company has roots in research at Lund University and has patented methods for developing new food categories in the growing plant-based food market. Lund Vegetables climate-smart and tasty products are sold in Europe and Asia under the DUG® Mark. The company’s stock is listed on the Nasdaq First North Growth Market under the symbol VOLAB. Learn more at ir.vegoflund.se. Mangold Fondkommission AB is the company’s certified advisor and can be contacted by telephone: +46 8 5030 15 50 or by e-mail: ca@mangold.se.

https://news.cision.com/veg-of-lund/r/warrants-of-series-to1-were-exercised-to-approximately-75-3-percent-and-veg-of-lund-receives- c3523755

https://mb.cision.com/Main/18795/3523755/1547521.pdf

(c) Decision 2022. All rights reserved., sources Press Releases – English

]]>
Alpha Exploration Ltd. – Grant of stock options https://piazzacarlogiuliani.org/alpha-exploration-ltd-grant-of-stock-options/ Tue, 08 Mar 2022 18:53:00 +0000 https://piazzacarlogiuliani.org/alpha-exploration-ltd-grant-of-stock-options/

Calgary, Alberta–(Newsfile Corp. – March 8, 2022) – Alpha Exploration Ltd. (TSXV: ALEX) (“Alpha“or the”Company“) announces its intention to grant 100,000 stock options to a director. The exercise price of the stock options has been set at C$0.66 and the stock options will be exercisable for a period of five years, until March 8, 2022 inclusively.

The granting of stock options is subject to the approval of the TSX Venture Exchange.

About Alpha

The company is focused on discovering world-class economic deposits of gold and base metals in the highly prospective Arabian-Nubian Shield, on either side of the Red Sea. Alpha currently owns a 100% interest in the large (771 km2) Kerkasha exploration permit in southwestern Eritrea on which 17 prospects have been identified to date. The large Anagulu gold-copper porphyry system was a pristine discovery by Alpha geologists in early 2018, which was made while running a region-wide soil sampling program. property. The discovery diamond hole was drilled in January 2020 and returned a 49m wide interval averaging 2.42 g/t gold, 1.10% copper and 6.83 g/t silver.

Cautionary Notes

This press release is for distribution in Canada only and is not for distribution to US news services or broadcast in the United States.

Forward-looking statements

Certain statements and information contained herein, including all statements that are not historical facts, contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements or information can be identified by the use of words such as “estimate”, “project”, “believe”, “anticipate”, “intend”, “expect to ”, “plan”, “predict”, “may” or “should” and the negative form of these words or such variations or comparable terminology are intended to identify forward-looking statements and information. With respect to forward-looking statements and information contained herein, Alpha has made numerous assumptions, including assumptions about general business and economic conditions and the price of gold and other minerals. The foregoing list of assumptions is not exhaustive.

Although Alpha’s management believes that the assumptions made and expectations represented by such statements or information are reasonable, there can be no assurance that any forward-looking statements or information contained herein will prove to be accurate. Forward-looking statements and information, by their nature, are based on assumptions and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or results of the industry, materially different from future results, performance or achievements. expressed or implied by such forward-looking statements or information. These factors include, but are not limited to: risks associated with Alpha’s funding efforts; risks associated with Alpha’s business given its limited operating history; business and economic conditions in the mining industry generally; supply and demand for labor and other project inputs; changes in commodity prices; changes in interest rates and currency exchange rates; risks related to inaccurate geological and technical assumptions (including with respect to tonnage, grade and recoverability of reserves and resources); risks related to unforeseen operational difficulties (including failure of equipment or processes to perform according to specifications or expectations, cost escalation, unavailability of materials and equipment, action governmental or delays in receiving governmental approvals, industrial disruptions or other business measures, and unforeseen health, safety and environmental events); weather-related risks; political risk and social unrest; changes in general economic or financial market conditions; changes in laws (including regulations regarding mining concessions); risks related to the direct and indirect impact of COVID-19, including, but not limited to, its impact on general economic conditions, the ability to obtain necessary financing and potential delays in the activities of exploration. and other risk factors as detailed from time to time. Alpha does not undertake to update forward-looking information except in accordance with applicable securities laws.

For more information, visit Alpha’s webpage at www.alpha-exploration.com or contact:

Michael Hopley
President and CEO
Alpha Exploration Ltd.
Email: mhopley@alpha-exploration.com
Tel: +44 207129 1148

Cautionary Notes

This press release is for distribution in Canada only and is not for distribution to US news services or broadcast in the United States.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/115996

]]>
Doley and Liberty Bank executives ring the closing bell at the New York Stock Exchange https://piazzacarlogiuliani.org/doley-and-liberty-bank-executives-ring-the-closing-bell-at-the-new-york-stock-exchange/ Fri, 18 Feb 2022 21:34:04 +0000 https://piazzacarlogiuliani.org/doley-and-liberty-bank-executives-ring-the-closing-bell-at-the-new-york-stock-exchange/

Ambassador Harold Doley

NEW ORLEANS — In 1973, New Orleans-based Liberty Bank helped New Orleans native Harold Doley buy a seat on the New York Stock Exchange. Half a century later, Doley was honored by the exchange and joined by Liberty Bank executives as he rang the bell that ended the trading day. The event took place on Friday, February 2. 18.

Doley, a former investment banker, bought his seat on the stock exchange with funding from Liberty Bank and Trust Company, which had been established less than a year earlier. He and Liberty Bank Chairman and CEO Alden J. McDonald Jr. appeared on the Today Show that year to mark the occasion.

Coming from a prominent New Orleans family, Doley began his career in 1968. He worked for Wall Street firms before buying his own headquarters. According to Wikipedia, he is the only African American to have owned a seat in part because the exchange no longer sells individual memberships. In the 1980s, Doley earned the title of United States Ambassador when he served as the country’s representative to the African Development Bank and Fund. The AfDB is a development finance institution owned by the governments of 50 African countries and 25 non-African countries, with 800 employees and assets of $50 billion.

“Funding Harold’s seat was a no-brainer,” McDonald said in a press release. “Freedom was born to help bring African Americans into the mainstream of the economy. There’s nothing more ‘mainstream’ than owning a seat on the world’s largest stock exchange.”

Liberty Bank and Trust is a designated MDI (Minority Depository Institution) offering personal, business, mortgage, auto, real estate, and “freedom fast” loans to customers. Liberty has since grown its assets to over $1 billion and expanded to 10 states. More information at www.libertybank.net

]]> Who is Allison Gollus? https://piazzacarlogiuliani.org/who-is-allison-gollus/ Wed, 02 Feb 2022 17:25:00 +0000 https://piazzacarlogiuliani.org/who-is-allison-gollus/

CNN Executive Vice President Allison Gollust has worked with public figures during her career and worked her way up with the news platform.

She has made a name for herself within the company, working with the marketing team and performing other roles.

2

Allison Gollust is CNN’s Senior Vice President.

Who is Allison Gollus?

Allison Gollus was chosen by former New York Governor Andrew Cuomo in 2012 as communications director.

She was previously executive vice president of corporate communications at NBC Universal alongside Jeff Zucker who was the chief enforcer at the time.

Gollus spent most of his career at NBC and formed relationships with his colleagues.

She got a job with the company in 1996 and only a year later was promoted to senior publicist for Today in NBC’s Corporate Communications group.

Did Allison Gollus work for Andrew Cuomo?

When Gollus left NBC, it was to work with former Governor Andrew Cuomo.

In a statement in October 2012, Cuomo described Gollus as “a consummate professional who has a wealth of communications and management experience.

“Her extraordinary work ethic, intelligence and dedication will be essential in this position, and I look forward to working with her.”

How long has Allison Gollus worked for CNN?

Gollus’ position at Cuomo lasted a year before she was hired by former CNN president and former NBC colleague Jeff Zucker.

Gollust was named CNN’s senior vice president in March 2013, and Zucker said at the time, according to CNN, “As we place even greater emphasis over the coming year on reinventing our content and , along with our brand, this is a key step in ensuring our success.”

His comments were released through a press release and he added, “Allison fully understands how every aspect of communications works together to tell a story, whether it’s on the PR side or the strategic marketing side. Combining these two areas under one proven leader just makes sense. »

She still retains her position and in a statement issued on February 2, 2022, Gollus said, “…I am incredibly proud of my time at CNN and look forward to continuing the great work we do every day.”

Allison Gollust and ex-husband Billy Hunt

2

Allison Gollust and ex-husband Billy HuntCredit: Getty

Is Allison Gollus married?

Although very little is known about Allison Gollus’ private life, she was reportedly married to Billy Hunt, president of Tradeweb.

Tradeweb is an international financial services company and their website states that they have “a rich history of fintech innovation in the fixed income and derivatives markets, and a growing equity business, our clients consistently benefit from better price discovery, order execution and trade workflows.”

Despite the couple’s success, they are divorced, but the official date remains unknown.

Gollust and Hunt share two children together, Olivia and Ava.

We pay for your stories!

Do you have a story for The US Sun team?

]]>
Vantage Capital arranges R430m mezzanine financing for Collins Residential, one of South Africa’s largest residential developers https://piazzacarlogiuliani.org/vantage-capital-arranges-r430m-mezzanine-financing-for-collins-residential-one-of-south-africas-largest-residential-developers/ Fri, 21 Jan 2022 10:45:44 +0000 https://piazzacarlogiuliani.org/vantage-capital-arranges-r430m-mezzanine-financing-for-collins-residential-one-of-south-africas-largest-residential-developers/

Vantage Capital (www.VantageCapital.co.za), Africa’s largest mezzanine fund manager, today announced that it has arranged a R430 million mezzanine financing for the development of Seaton Estates, a coastal residential development located on the north coast of Kwa-Zulu Natal, South Africa. The promoter of the transaction is Collins Residential, the residential arm of a diversified group with interests in the property, hospitality and agricultural sectors, both in South Africa and internationally. The Collins Group is a multi-generational family business, led by Murray Collins, which has its roots in construction since the early 1900s. Collins Residential has a proven track record in KwaZulu Natal, with previous developments including the Zululami Luxury Coastal Estate recently completed (adjacent to Seaton development), Mount Edgecombe Retirement Village and Emberton Estate.

Seaton Estates seeks to meet the growing need for residential accommodation in the mid to upper segments of the property market along the North Coast of KwaZulu Natal, one of South Africa’s fastest growing regions. Growth in housing demand is supported by strong out-migration trends, strong infrastructure investment in the region and the increased flexibility for South Africans to work from home, a lasting consequence of the Covid-19 pandemic. 19.

The Seaton Estates development sits on prime property with direct and exclusive access to one kilometer of beachfront. Seaton comprises 1198 unique residential settlements and 29 planned urban developments, spread over 7 phases. The development is designed to be an eco-friendly coastal estate characterized by countryside grasslands, ocean views and reclaimed native forest land. Development facilities will include recreation areas, a beach club, direct beach access, multi-sports facilities, 26km cycle/running paths and rehabilitated forests and natural parks. Later stages of development will include mixed-use commercial nodes, retail, educational and sports facilities. The development is close to the popular recreation towns of Salt Rock and Ballito.

Murray Collins the managing director of Collins Residential said: “Seaton represents a unique way of life on a large scale. As developers of this iconic estate, we are driven by a genuine commitment to the conservation and preservation of the natural landscape while designing within the framework of sustainable and meaningful development, to dramatically elevate the North Coast of KZN.

This transaction represents the 32n/a Mezzanine investment across four generations of funds in eleven African countries. Outside of South Africa, Vantage has invested in ten jurisdictions including Egypt, Morocco, Ivory Coast, Ghana, Nigeria, Uganda, Kenya, Mauritius, Namibia and Botswana.

Luc Albinsky, Chairman of Vantage Capital said: “KwaZulu Natal has been hit hard by the recent riots. We are delighted to be able to help restore confidence in the region by making our first mezzanine investment from Vantage’s fourth fund in this magnificent project, which will generate hundreds of jobs over its seven-year construction period.

Rochal Ramdenee, Associate Partner at Vantage Capital, added: “We are proud to support one of South Africa’s leading residential developers in what will be a transformative development for the North Coast of KwaZulu Natal. Seaton Estates directly meets the needs of buyers in a booming economic hub, while providing unparalleled access to world-class facilities and beautiful eco-friendly habitat.

Adaptive Consulting acted as financial advisor to the transaction, Werksmans Attorneys acted as legal advisor to Vantage, and other advisors included Webber Wentzel, PWC, JLL, Pro Africa, Citeplan and IBIS Consulting.

Distributed by APO Group on behalf of Vantage Capital Group.

For more information contact:
Luc Albinsky
President
[email protected]
Tel: +27 83 390 7703

Roshal Ramdene
Associate partner
[email protected]
Tel: +27 78 147 7839

About Vantage Capital:
Vantage Capital Group was established in 2001 and is the largest independent pan-African mezzanine debt fund manager on the African continent. It has raised over $1.4 billion in seven separate technology, mezzanine and renewable energy debt funds and has made 56 investments on the African continent to date.

Vantage has offices in Johannesburg and Cape Town and typically targets $10m to $40m mezzanine debt opportunities in more than a dozen key African markets. Mezzanine debt is an intermediate form of venture capital, which sits between senior debt, the least risky slice of the capital structure, and equity, the most risky. It combines debt and equity elements, providing companies with long-term financing on terms that are less dilutive to shareholders than pure equity.

Website: www.VantageCapital.co.za

This press release was issued by APO. Content is not vetted by the African Business editorial team and none of the content has been verified or validated by our editorial teams, proofreaders or fact checkers. The issuer is solely responsible for the content of this announcement.

]]>
Biotricity Expands Distribution of New Bioheart Device on Amazon.com https://piazzacarlogiuliani.org/biotricity-expands-distribution-of-new-bioheart-device-on-amazon-com/ Tue, 28 Dec 2021 14:41:37 +0000 https://piazzacarlogiuliani.org/biotricity-expands-distribution-of-new-bioheart-device-on-amazon-com/


Receive instant alerts for news on your actions. Claim your 1-week free trial for Street Insider Premium here.


New heart monitoring solution delivers personalized heart health information right to your smartphone

Now easy to buy and use: No prescription needed for an advanced heart and lifestyle solution

REDWOOD CITY, CA / ACCESSWIRE / December 28, 2021 / Biotricity Inc. (NASDAQ: BTCY), a modern medical technology company providing innovative remote biometric monitoring solutions, today announced that it has expanded distribution of its new Bioheart heart monitor system, a direct-to-consumer device that offers the same continuous heart monitoring. technology used by doctors, on Amazon.com.

Last month, the company launched commercial sales of its Bioheart device. To improve availability and extend reach, Biotricity is now listing it on Amazon.com at: Bioheart on Amazon for $ 199 with a special introductory price of $ 149 for a limited time. You can see the Bioheart heart monitor in use here.

“We aim to transform the heart health market and believe the Bioheart system will play an important role in this effort,” said Dr. Waqaas Al-Siddiq, Founder and CEO of Biotricity, “The Bioheart device is an important part of our full spectrum, virtual heart clinic “of mobile heart care and lifestyle solutions. It will be fully integrated with a growing number of cardiology practices through our cloud-based Biosphere ecosystem that we plan to fully deploy in 2022, allowing physicians to gain a more holistic view of a patient’s health.

“The ability to offer Bioheart on Amazon extends the availability for the public to easily access the benefits of this exciting technology,” added Dr Waqaas.

The launch of Bioheart opens up a new market and revenue stream for Biotricity while expanding the company’s total addressable market by $ 1.24 billion. Heart disease is intermittent, requiring long-term data collection for effective information and lifestyle management. With continuous monitoring, Bioheart is reinventing personal cardiac management with retrospective snapshots and long-term data collection.

With a revolutionary new feature, users can collect data for hours, days, weeks, months and even years! They can create snapshots of rhythm data by examining past data and tagging it for personal recordings. These are one-of-a-kind features that will help individuals examine their data for a better understanding of the impact on their lifestyle and heart health.

Bioheart features include:

  • Integrated dry contacts for data collection
  • Advanced data collection – three different heart views
  • Continuous recording of the rhythm 24/7
  • 48 hour battery life
  • Custom analyzes
  • Bluetooth connected

With the Bioheart smartphone app, users can:

  • View the electrical heart rate live on the app
  • View data on advanced heart measurements such as electrical heart rate, heart rate, and heart rate variability
  • View historical heart rate ranges
  • Create a heart rate diary and save snapshots of heart activity
  • Easily create retrospective snapshots, a unique feature
  • Easily export and share heart data with a doctor

Bioheart incorporates the company’s proprietary advanced cardiac technology, combined with powerful analytics and continuous rhythm recording, to help individuals understand and improve their heart health. Individuals can track their heart statistics 24/7 with three different views of the heart, which can be streamed live on the Bioheart smartphone app. Bioheart is the most accurate heart monitor available without a prescription.

Bioheart retails for $ 199 and is available for the special price of $ 149, for a limited time, on Amazon or www.bioheart.com. The application is available on the Apple App Store and on Google Play.

About Biotricity Inc.

Biotricity is reforming the healthcare market by bridging the gap between remote monitoring and chronic care management. Physicians and patients trust Biotricity’s unmatched standard for preventive and personal care, including diagnostic and post-diagnostic solutions for chronic disease. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com.

The Bioheart name, logo and taglines are trademarks of Biotricity Inc. US and international patents pending. Bioheart does not require a prescription.

Bioheart does not diagnose, treat, or repair heart disease. Bioheart is not intended to be a diagnostic tool, or for clinical use, or clinical interpretation, and is intended to be a lifestyle and wellness solution for individuals. If users of the Bioheart are concerned about the data obtained from the device, they should consult a healthcare practitioner directly for further advice. Biotricity disclaims any representation made, explicitly or implicitly, which would suggest that the accuracy of the data obtained lends itself to clinical interpretation.

Bioheart as described here, and later versions, may or may not be the same as advertised and may or may not differ in features and functionality. All statements made here about Bioheart, its specifications, its functionality are based on the design and concepts the company considers feasible, but the functionality may be different.

Important Cautions Regarding Forward-Looking Statements

All statements in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, strategies and expectations, are generally identifiable by the use of the words “may”, “should”, “would”, “will”, “could”, “,” “Expect”, “anticipate”, “estimate”, “believe”, “intend”, “seek”, “project” or “objective” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements may include, without limitation, statements regarding (i) management’s plans, objectives and goals for future operations, including plans, objectives or goals relating to the design, development and marketing of Bioflux or any other Company project products or services, (ii) a projection of income (including income / loss), profits (including profits / losses) per share, capital expenditure, dividends, capital structure or other financial elements, (iii) the future financial performance of the Company, (iv) the regulatory regime in which the Company operates or intends to operate and (v) the assumptions under – adjacent or linked to any declaration described in points (i), (ii), (iii) or (iv) above. These forward-looking statements are not intended to predict or guarantee actual results, performance, events or circumstances and may not be made because they are based on current projections, plans, objectives, beliefs, expectations, estimates and assumptions. of the Company and are subject to a number of risks and uncertainties and other influences, over which the Company has no control. The actual results and timing of certain events and circumstances may differ materially from those described in forward-looking statements due to these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the inability of the Company to obtain additional funding, the length of time and significant resources associated with the development of its products and the resulting insufficient cash flow and resulting illiquidity, the Company’s inability to develop its business, significant government regulation of medical devices and healthcare sector, lack of product diversification, existing or increased competition, results of arbitration and litigation, volatility and illiquidity of shares, and the failure of the Company to implement plans or the Company’s business strategies. These and other factors are identified and described in more detail in the Company’s filings with the SEC. There can be no assurance that the Company will ever become profitable. During the quarter ended June 30, 2020, the Company incurred a net loss attributable to common shareholders of $ 3.4 million. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this press release.

CONTACTS
Media
Bospar
prforbiotricity@bospar.com

Investor Relations
Biotricity Investor Relations
Investors@biotricity.com
1.800.951.3348

Marc Forney
MKR Group, Inc.
12198, boulevard Ventura, bureau 200
Los Angeles, California 91604
mark@mkrir.com

THE SOURCE: Biotricity, Inc.

See the source version on accesswire.com:
https://www.accesswire.com/679831/Biotricity-Expands-Distribution-of-New-Bioheart-Device-on-Amazoncom

]]>
VEON concludes bank financing of 90 billion RUB (approximately 1.2 billion USD) https://piazzacarlogiuliani.org/veon-concludes-bank-financing-of-90-billion-rub-approximately-1-2-billion-usd/ Fri, 24 Dec 2021 06:00:00 +0000 https://piazzacarlogiuliani.org/veon-concludes-bank-financing-of-90-billion-rub-approximately-1-2-billion-usd/

AMSTERDAM, December 24, 2021 / PRNewswire / – VEON Ltd. (NASDAQ: VEON) (Euronext Amsterdam: VEON), a leading global provider of connectivity and internet services, announces that VEON Finance Ireland Designated Activity Company., A subsidiary of VEON Ltd. (NASDAQ, Euronext Amsterdam: VEON) successfully completed the bank financing of 90 billion rubles (about $ 1,215 million[1]) guaranteed by VEON Holdings BV.

VEON has entered into two bilateral loan facilities of 45 billion rubles each with Sberbank and Alfa Bank.

  • the 45 billion rubles The Alfa Bank facility has an amortization period of 5 years with a 30 billion rubles fixed rate tranche and a 15 billion rubles variable rate tranche
  • the 45 billion rubles The Sberbank facility has an amortization period of 5 years and is fully floating

The proceeds of the two facilities will be used for general corporate purposes, including the financing of intercompany loans to PJSC VimpelCom.

Serkan Okandan, VEON’s CFO, said: “These new facilities show the continued good progress of our efforts to improve the Group’s capital structure and extend the maturity of our debt portfolio.

[1]Based on USD / RUB = 73.92

Warning

This press release contains “forward-looking statements” as defined in Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts and include statements relating, among other things, to expectations regarding the financial condition and capital structure of VEON. Forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with precision and some of which may not even be anticipated by VEON. The forward-looking statements contained in this press release speak only as of the date of this press release. VEON does not undertake to publicly update, except as required by US federal securities laws, any forward-looking statements to reflect events or circumstances after these dates or to reflect the occurrence of unforeseen events.

About VEON

VEON is a global connectivity and internet service provider listed on NASDAQ and Euronext Amsterdam. For more information, visit: www.veon.com.

Contact details
VEON
Investor Relations
Nik Kershaw
[email protected]
+31 20 79 77 200

SOURCE VEON SA

]]>
Interfor expands and expands its revolving credit facility https://piazzacarlogiuliani.org/interfor-expands-and-expands-its-revolving-credit-facility/ Fri, 17 Dec 2021 23:21:42 +0000 https://piazzacarlogiuliani.org/interfor-expands-and-expands-its-revolving-credit-facility/

Content of the article

BURNABY, British Columbia, December 17, 2021 (GLOBE NEWSWIRE) – INTERFOR COMPANY (“Interfor” or the “Company”) (TSX: IFP) today announced that it has entered into an early renewal and expansion of its revolving credit facility with a syndicate of major Canadian and US banks co-led by RBC Capital Markets, TD Securities and Wells Fargo.

The amount of the commitment under the facility has been increased by C $ 150 million to a total of C $ 500 million, and the term of the facility has been extended from March 2024 to December 2026. restrictive clauses and the pricing schedule remain unchanged. In addition, the renewal includes the increased ability to obtain additional long-term debt financing, which will improve the Company’s continued financial flexibility.

Content of the article

As of September 30, 2021, Interfor had C $ 836 million in available liquidity, including C $ 509 million in cash, and this availability will be increased by C $ 150 million on a pro forma basis under the new facility. This increase will provide the Company with sufficient financial capacity to complete its previously announced acquisition of EACOM Timber Corporation in early 2022 and provide additional flexibility to continue to pursue its strategic growth program.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking information about the business prospects, objectives, plans, strategic priorities and other information of the Company which are not historical facts. A statement contains forward-looking information when the Company uses what it knows and expects today to make a statement about the future. Statements containing forward-looking information in this press release include, without limitation, statements regarding future growth, pro forma liquidity, borrowing capacity, expected completion of a transaction and other future events and circumstances. . Readers are cautioned that actual results may differ from the forward-looking information contained in this press release, and that such forward-looking information should not be relied on unduly. The risk factors which could cause actual results to differ materially from the forward-looking information contained in this press release are described in Interfor’s annual management report under the heading “Risks and Uncertainties”, which is available at www.interfor. com and under the Interfor profile. at www.sedar.com. Important factors and assumptions used in developing the forward-looking information in this press release include the volatility of the selling prices of lumber, logs and wood chips; the Company’s ability to compete globally; the availability and cost of log supply; natural or man-made disasters; exchange rate; changes in government regulations; the availability of the Company’s annual harvest opportunity (“AAC”); claims of indigenous peoples and treaty agreements with them; the Company’s ability to export its products; the softwood lumber trade dispute between Canada and the United States; stumpage fees payable to the Province of British Columbia (“BC”); the environmental impacts of the Company’s operations; work interruptions; information systems security; and the existence of a public health crisis (such as the current COVID-19 pandemic). Unless otherwise indicated, the forward-looking statements contained in this press release are based on the Company’s expectations as of the date of this press release. Interfor assumes no obligation to update such forward-looking information or statements, except as required by law.

ABOUT INTERFOR

Interfor is a growth-oriented forest products company with operations in Canada and the United States. The company has an annual production capacity of approximately 3.9 billion board feet and offers a diverse line of lumber products to customers around the world. For more information about Interfor, visit our website at www.interfor.com.

Investor contacts:

Rick Pozzebon, Senior Vice President and Chief Financial Officer
(604) 689-6804

Mike Mackay, Vice President of Corporate Development and Strategy
(604) 689-6846

Main logo

]]>
Third quarter 2021 results – ‘Third record -4- https://piazzacarlogiuliani.org/third-quarter-2021-results-third-record-4/ https://piazzacarlogiuliani.org/third-quarter-2021-results-third-record-4/#respond Fri, 12 Nov 2021 06:02:07 +0000 https://piazzacarlogiuliani.org/third-quarter-2021-results-third-record-4/

1 The financial information contained in this press release and in appendix 1 has been prepared in accordance with the evaluation and recognition criteria of International Financial Reporting Standards (“IFRS”) as adopted in the European Union. Although the interim financial information included in this announcement has been prepared in accordance with IFRS applicable to interim periods, this announcement does not contain sufficient information to constitute an interim financial report as defined in International Accounting Standard 34, “Interim Financial Reporting “. Unless otherwise indicated, the figures and information contained in the press release have not been audited. The financial information and certain other information presented in a number of tables in this press release have been rounded to the nearest whole number or to the nearest decimal place. Therefore, the sum of the numbers in a column may not exactly match the total number given for that column. In addition, certain percentages presented in the tables in this press release reflect calculations based on the underlying information before rounding and, therefore, may not be exactly in line with the percentages that would be derived if the relevant calculations were based. on rounded numbers.

2 The Leadership Journey (R) is an initiative launched on December 16, 2010, then accelerated and scaled up, to target management gains and profit improvement. The fourth phase of the Leadership Journey (R) targets 150 million euros in earnings for the period 2021 – 2023 through a combination of measures to improve costs, growth and mix.

3,105 million euros of share buybacks during the first nine months of 2021 consist of (1) 100 million euros related to the share buyback program announced on July 30, 2021 and finalized during the third quarter 2021 with the acquisition of 1.96 million shares and (2) 5 million euros related to the acquisition of 0.10 million shares from a related party during the second quarter of 2021.

4 This press release also includes Alternative Performance Measures (“APM” hereafter). The Company believes that these NPAs are relevant to improving the understanding of its financial position and provide additional information to investors and management regarding the financial performance, capital structure and credit rating of the Company. These non-GAAP financial measures should be read in conjunction and not as an alternative to Aperam’s financial information prepared in accordance with IFRS. These non-GAAP measures may not be comparable to measures of the same name applied by other companies. The NPAs used are defined in appendix 2 “Terms and definitions”.

————————————————– ————————————————– ——————-

Distribution of a Financial Wire News, transmitted by EQS Group. The issuer is solely responsible for the content of this advertisement.

————————————————– ————————————————– ——————-

1248509 12-Nov-2021 CET / CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1248509&application_name=news

(END) Dow Jones Newswires

November 12, 2021 01:01 ET (06:01 GMT)

]]>
https://piazzacarlogiuliani.org/third-quarter-2021-results-third-record-4/feed/ 0